Fig 1.
Distribution of the survey sites.
Note(hospital): CHXUAR: Chest Hospital of Xinjiang Uygur Autonomous Region; SCH: Shenyang Chest Hospital; BCHACUMC: Beijing Chest Hospital Affiliated to Capital University of Medical Sciences; SAHPGH: The Second Affiliated Hospital of the PLA General Hospital; THH: Tianjin Haihe Hospital; FPHTC: The Fourth People 's Hospital of Taiyuan City; HPCH: Hebei Province Chest Hospital; SPCH: Shandong Province Chest Hospital; FAHXMC: The First Affiliated Hospital of Xinxiang Medical College; TPHZC: The Third People 's Hospital of Zhenjiang City; NCH: Nanjing Chest Hospital; SPHATU: Shanghai Pulmonary Hospital Affiliated to Tongji University; SXDCH: Shanghai Xuhui District Central Hospital; SPHCC: Shanghai Public Health Clinical Center; WITPC: Wuhan Institute of Tuberculosis Prevention and Control; CMPHMTC: Chongqing Municipal Public Health Medical Treatment Center; ZCCMH: Zigong City Chinese Medicine Hospital; CCH: Changsha Central Hospital; HPTH: Hunan Provincial Tuberculosis Hospital; JPCH: Jiangxi Provincial Chest Hospital; LHGZAR: Longtan Hospital of Guangxi Zhuang Autonomous Region; TPHSC: The Third People 's Hospital of Shenzhen City.
Fig 2.
Study population of MDR-TB in 22 hospitals in 17 provinces of China.
Table 1.
Social demographic characteristics of subjects.
Table 2.
Clinical characteristics of subjects.
Table 3.
Imaging characteristics of subjects.
Table 4.
Univariate risk factors associated with drug resistance pattern.
Fig 3.
Multivariate logistic regression analysis of the resistant pattern.